Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam M Deane

Showing results (231-240 of 259) with videos related to

Pageof 26
Sort By:
Critical Care Medicine|March 7, 2018
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin IIJames A Tumlin, Raghavan Murugan, Adam M Deane, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Increasing protein dose does not further augment muscle protein synthesis in critical illness: A Randomized, Controlled Clinical TrialMatthew J Summers, Imre W K Kouw, Imogen E Asser, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|October 24, 2018
Opinions and practices of blood glucose control in critically ill patients with pre-existing type 2 diabetes in Australian and New Zealand intensive care unitsAlexis P Poole, James Anstey, Rinaldo Bellomo, et al.
Trials|February 6, 2025
TARGET Protein: the effect of augmented administration of enteral protein to critically ill adults on clinical outcomes-statistical analysis plan for a cluster randomized, cross-sectional, double cross-over, clinical trialSophie Zaloumis, Matthew J Summers, Jeffrey J Presneill, et al.
American Journal of Respiratory and Critical Care Medicine|January 7, 2020
Outcomes Six Months after Delivering 100% or 70% of Enteral Calorie Requirements during Critical Illness (TARGET). A Randomized Controlled TrialAdam M Deane, Lorraine Little, Rinaldo Bellomo, et al.
BMJ Open|May 19, 2023
What counts as patient-important upper gastrointestinal bleeding in the ICU? A mixed-methods study protocol of patient and family perspectivesDeborah J Cook, Marilyn Swinton, Karla D Krewulak, et al.
Critical Care (London, England)|September 20, 2019
Metabolic support in the critically ill: a consensus of 19Jan Wernerman, Kenneth B Christopher, Djillali Annane, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
Study protocol for TARGET protein: The effect of augmented administration of enteral protein to critically ill adults on clinical outcomes: A cluster randomised, cross-sectional, double cross-over, clinical trialMatthew J Summers, Lee-Anne S Chapple, Rinaldo Bellomo, et al.
JAMA|June 11, 2025
Augmented Enteral Protein During Critical Illness: The TARGET Protein Randomized Clinical TrialMatthew J Summers, Lee-Anne S Chapple, Amalia Karahalios, et al.
Journal of Critical Care|March 6, 2024
Patient-important upper gastrointestinal bleeding in the ICU: A mixed-methods study of patient and family perspectivesMeredith G Vanstone, Karla Krewulak, Shipra Taneja, et al.
Pageof 26

Showing results (231-240 of 259) with videos related to

Sort By:
Pageof 26
Critical Care Medicine|March 7, 2018
Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin IIJames A Tumlin, Raghavan Murugan, Adam M Deane, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Increasing protein dose does not further augment muscle protein synthesis in critical illness: A Randomized, Controlled Clinical TrialMatthew J Summers, Imre W K Kouw, Imogen E Asser, et al.
Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|October 24, 2018
Opinions and practices of blood glucose control in critically ill patients with pre-existing type 2 diabetes in Australian and New Zealand intensive care unitsAlexis P Poole, James Anstey, Rinaldo Bellomo, et al.
Trials|February 6, 2025
TARGET Protein: the effect of augmented administration of enteral protein to critically ill adults on clinical outcomes-statistical analysis plan for a cluster randomized, cross-sectional, double cross-over, clinical trialSophie Zaloumis, Matthew J Summers, Jeffrey J Presneill, et al.
American Journal of Respiratory and Critical Care Medicine|January 7, 2020
Outcomes Six Months after Delivering 100% or 70% of Enteral Calorie Requirements during Critical Illness (TARGET). A Randomized Controlled TrialAdam M Deane, Lorraine Little, Rinaldo Bellomo, et al.
BMJ Open|May 19, 2023
What counts as patient-important upper gastrointestinal bleeding in the ICU? A mixed-methods study protocol of patient and family perspectivesDeborah J Cook, Marilyn Swinton, Karla D Krewulak, et al.
Critical Care (London, England)|September 20, 2019
Metabolic support in the critically ill: a consensus of 19Jan Wernerman, Kenneth B Christopher, Djillali Annane, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|October 25, 2023
Study protocol for TARGET protein: The effect of augmented administration of enteral protein to critically ill adults on clinical outcomes: A cluster randomised, cross-sectional, double cross-over, clinical trialMatthew J Summers, Lee-Anne S Chapple, Rinaldo Bellomo, et al.
JAMA|June 11, 2025
Augmented Enteral Protein During Critical Illness: The TARGET Protein Randomized Clinical TrialMatthew J Summers, Lee-Anne S Chapple, Amalia Karahalios, et al.
Journal of Critical Care|March 6, 2024
Patient-important upper gastrointestinal bleeding in the ICU: A mixed-methods study of patient and family perspectivesMeredith G Vanstone, Karla Krewulak, Shipra Taneja, et al.
Pageof 26